Form 4: Harrow Inc. Insider Reports Restricted Stock Units Grant

Amir Shojaei, Chief Scientific Officer of Harrow Inc., received a grant of 10,000 restricted stock units.

Summary

• Amir Shojaei, Chief Scientific Officer at Harrow Inc. (HROW), was granted 10,000 restricted stock units (RSUs) on May 15, 2026.
• These RSUs represent a contingent right to receive one share of Harrow, Inc. common stock.
• The RSUs will vest in full on May 15, 2029, provided Shojaei remains in continuous service with the company until that date.
• The transaction was reported on May 18, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard executive compensation event rather than a significant financial or strategic development.

Positives

• Grant of 10,000 restricted stock units to a key executive, indicating continued investment in and retention of scientific leadership.
• The vesting schedule ties executive compensation to continued service, aligning management interests with long-term company performance.

Risks

• The value of the RSUs is contingent on the continued service of Amir Shojaei through May 15, 2029.
• The value of the RSUs is subject to the future stock price performance of Harrow Inc.

Future Outlook

The restricted stock units are set to vest on May 15, 2029, contingent upon the reporting person's continued employment with Harrow, Inc. through that date.

Industry Context

StockSavvy.ai notes that the issuance of restricted stock units is a common form of executive compensation in the biotechnology and pharmaceutical sectors, used to incentivize long-term commitment and align executive interests with shareholder value.

Stakeholder Impact

• Shareholders: The grant of RSUs represents potential future dilution if the stock price increases significantly, but also signals retention of key scientific talent.
• Employees: May be seen as a standard compensation practice, potentially impacting morale depending on overall compensation structures.
• Management: Reinforces the alignment of executive incentives with company performance and long-term value creation.

Next Steps

• Amir Shojaei must remain employed by Harrow, Inc. until May 15, 2029, for the restricted stock units to vest.
• Upon vesting, Shojaei will receive 10,000 shares of Harrow, Inc. common stock.

Key Dates

Keywords

Harrow Inc., HROW, Form 4, Insider Trading, Restricted Stock Units, RSU Grant, Executive Compensation, Amir Shojaei, Chief Scientific Officer, Vesting Schedule